Clinical Trial Update: Badalona Major Depressive Disorder Database Study

View source ↗

Summary

AstraZeneca-sponsored database study investigating Major Depressive Disorder has completed in Badalona. The trial identifier is NCT01446692.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: AstraZeneca | Conditions: Major Depressive Disorder | Status: COMPLETED